Business Overview & Highlights - 科伦博泰是一家致力于肿瘤学、免疫学和其他治疗领域新药的开发、制造和商业化的生物制药公司[14] - 公司有30多个在研药物，其中4个处于临床阶段，并且有超过1870名全职雇员[20] - 公司有3款产品上市，并且已经提交了5个新药申请(NDAs)[20] - 公司与默沙东就多个ADC资产展开合作，包括SKB410/MK-3120, SKB571/MK-2750, SKB535/MK-6204[30] Commercialization - 公司商业销售总额达3.098 亿元人民币，其中sac-TMT (佳泰莱®)销售占比为97.6%[53] - 公司已组建了一支人数超过350人的营销团队，覆盖30个省份和300多个城市，目标医院数超过2000家[57] - 佳泰莱®已完成29个省挂网，科泰莱®已完成25个省挂网，达泰莱®已完成15个省挂网[62] Financial Performance - 公司收入从2024年上半年的13.82791亿人民币减少到2025年上半年的9.50445亿人民币[85, 95] - 公司毛利从2024年上半年的10.7669亿人民币减少到2025年上半年的6.59988亿人民币[85, 95] - 公司研发费用从2024年上半年的6.52337亿人民币减少到2025年上半年的6.11539亿人民币[89, 95]

Tongcheng Travel Holdings Limited Stock Code: 0780 Investor Presentation August 2025 Disclaimer The materials used in this investors presentation are being furnished to you for your information only, which shall be kept in strict confidence. No representation or warranty, express or implied, is made by Tongcheng Travel Holdings Limited (the "Company") or its connected person, or any of their respective directors, officers, employees, advisers or representatives as to, and no reliance should be placed on, th ...

Financial Performance - Group revenue reached RMB 6838 million, a 71% year-over-year increase[3] - Operating profit increased by 91% to RMB 1305 million, with an operating profit margin of 191%[3] - Profit attributable to ordinary equity holders of the company increased by 215% to RMB 914 million[3] - Basic earnings per share increased by 165% to RMB 346 cents[6] Segment Performance - Mass market revenue increased by 45% to RMB 6053 million[3, 11] - Professional sports revenue increased significantly by 325% to RMB 785 million[3, 11] Balance Sheet Highlights - Net cash and cash equivalents increased significantly by 943% to RMB 1913 million[7] - Shareholders' equity increased by 135% to RMB 9876 million[7] Brand Performance & Strategy - Xtep is the No 1 running brand in China, with leading overall wear rate in major marathons[18, 19] - Core Xtep brand revenue increased, with footwear accounting for 584% of revenue[75] - Saucony & Merrell brands experienced revenue growth, with overall revenue increasing by 325%[83] Sustainability - The company recycled approximately 3000 kg of clothes and reduced carbon emissions by over 10000 kg[52, 53]

Financial Performance - PAX Global Technology Limited reported revenue of HK$2,716 million for 1H 2025, compared to HK$3,013 million in 1H 2024[8, 36] - Profit for the period was HK$391 million in 1H 2025, compared to HK$460 million in 1H 2024[8, 36] - Gross profit margin increased slightly from 46.8% in 1H 2024 to 46.9% in 1H 2025[8, 36] - The company declared an interim dividend of HK 25 cents per share, with a payout ratio of 67.8%[10] Cash Flow and Working Capital - Net cash generated from operating activities was HK$154 million[14, 39] - Payments in dividends and buybacks amounted to HK$275 million[14, 39] - Trade and bills receivables increased by 8.3% year-over-year, with a turnover of 182 days[15] - Inventories decreased by 4.4% year-over-year, with a turnover of 230 days[15] - Trade payables decreased by 11.1% year-over-year, with a turnover of 118 days[16] Regional Performance - EMEA (Europe, the Middle East and Africa) contributed the largest share of revenue at HK$1,084 million, representing 40% of total revenue[27] - LACIS (Latin America and the Commonwealth of Independent States) contributed HK$684 million, representing 25% of total revenue[24] - USCA (United States of America and Canada) contributed HK$499 million, representing 18% of total revenue[25] - APAC (Asia Pacific Region) contributed HK$449 million, representing 17% of total revenue[28]

(Stock Code: 1177.HK) (RMB bn) 2025 2025 Interim Results Announcement 2025.8.18 Hong Kong CONTENTS Financial Highlights Pipeline Highlights 2 Financial Highlights Both revenue and profit achieved double-digit growth 1.54 3.09 2024 H1 Continuing Operations 2025 H1 Continuing Operations Revenue 15.87 17.57 2024 H1 Continuing Operations 2025 H1 Continuing Operations Profit attributable to owners of the parent (as reported) 1.41 3.39 2024 H1 Continuing Operations 2025 H1 Continuing Operations Profit attributabl ...

Financial Performance - The Group's revenue from continuing operations reached $518.8 million, marking an impressive 81.9% year-over-year increase compared to H1 2024[5,65] - Adjusted net profit from continuing operations soared to $178.0 million, a substantial 509.6% increase compared to the $29.2 million in H1 2024[5,65] - GenScript revenue increased by 11.3% to $247.6 million[65,67] - ProBio experienced significant growth, with revenue reaching $246.9 million, a 511.1% increase[5,65,70] - Bestzyme's revenue grew by 8.4% to $28.3 million[65,73] GenScript Highlights - GenScript served over 42,000 customers in H1 2025, up from 39,000+ in H1 2024[18] - The number of scientific journals citing GenScript increased to over 112,000, compared to 100,000+ in H1 2024[18] - R&D functions account for approximately 10% of the 5700+ employees globally[6] ProBio Highlights - ProBio's cash position is $371.1 million[70] - 20 CDMO projects in H1 2025, with >50% from global customers[42] Bestzyme Highlights - Bestzyme's R&D expenses increased by 62%, from $2.9 million in H1 2024 to $4.7 million in H1 2025[59] - International revenue contribution increased, accounting for 23% of revenue in H1 2025 compared to 21% in H1 2024[73] Guidance - The company revised its revenue growth target for FY 2025 from 10%-15% to 13%-15%[78] - Bestzyme expects 20%-25% revenue growth with Adjusted GPM ~45%[78]

SITC International Holdings Company Limited (Stock Code: HK1308) August 2025 Disclaimer This document does not constitute an offer to sell or issue or the solicitation of an offer to buy or acquire securities of SITC International Holdings Company Limited (the "Company") in any jurisdiction or an inducement to enter into investment activity, nor may it or any part of it form the basis of or be relied on in connection with any contract or commitment whatsoever. Specifically, this document does not constitute ...

Financial Performance - Revenue decreased slightly by 1% from HK$10,501 million to HK$10,437 million[9] - Renewable Energy Business Net Profit increased by 5% from HK$164 million to HK$172 million[9] - Capital Expenditure decreased from HK$2 billion to HK$1.4 billion[12] Gas Business - Gas sales volume remained steady at 8.75 billion m³[5] - City Gas Dollar Margin increased by RMB 0.01/m³ to RMB 0.57/m³[5] - Operating expenses decreased by 6% due to optimized personnel structure[20] - Signed a 15 billion m³ pipeline gas LTA with the "Three Majors", amounting to 1.5 billion m³/year[4] - Secured LNG import supply of 1.5 million tonnes/year, equivalent to 2.1 billion m³/year[4] Renewable Energy - PV power generation increased by 44% to 1.18 billion kWh[4, 5] - Accumulated PV Grid-connected capacity increased by 0.3 GW to 2.6 GW[5] - Electricity trading volume increased by 14% to 3.64 billion kWh[5] - Secured 775 MWh in Energy Storage System (ESS) contracts[4] - Two tranches of quasi-REITs raised approximately RMB 1 billion[4, 38]

Financial Performance - The company's turnover increased by 2.2% compared to the first half of 2024[10,92] - Recurring underlying profit increased by 1.2% compared to the first half of 2024[10,92] - Underlying profit increased by 1.2% compared to the first half of 2024[10,92] - HK$15.3 billion in undrawn committed facilities and cash provides ample liquidity[74,156] - Shareholders' Fund is HK$65.2 billion, NAV per share is HK$63.5, and DPS is HK$0.27[72,154] Portfolio Performance - Hong Kong office occupancy is at 92% as of June 30, 2025[10,45,66,127,149] - Hong Kong residential occupancy is at 94% as of June 30, 2025[10,45,127] - Hong Kong retail occupancy is at 70% as of June 30, 2025[10,45,127] - Hong Kong retail revenue increased by 0.8% year-over-year[46,128] - Hong Kong office revenue decreased by 2.4% year-over-year[46,128] Strategic Initiatives - Lee Garden Eight is on track for completion in 2026, expecting a 30% expansion of the Lee Gardens leasable portfolio and a 20% increase in daily footfall[33,37,116,119] - Targeting HK$8 billion over 5 years through capital recycling from non-core assets like Bamboo Grove and VILLA LUCCA[69,151]

Financial Highlights - Revenue increased by 3% to HK$2407 billion in 1H 2025[6] - Net earnings decreased by 92% to HK$09 billion in 1H 2025, but underlying net earnings increased by 11%[6] - EPS decreased by 92% to $022 in 1H 2025, but underlying EPS increased by 11%[6] - EBITDA decreased by 14% to $450 billion in 1H 2025, but underlying EBITDA increased by 7%[7] - Operating Free Cash Flow increased by 11% to $218 billion in 1H 2025[7] - Free Cash Flow increased by 248%[17] Segment Performance - Ports and Related Services revenue increased by 9% to HK$23597 million[71], with throughput increasing by 4% to 440 million TEUs[26] - Retail revenue increased by 8% to HK$98840 million[71], with a 2% increase in store numbers to 16935[28] - Infrastructure revenue increased by 6% to HK$28627 million[71] - CK Hutchison Group Telecom revenue increased by 5% to HK$45012 million[71] - Finance & Investments and Others revenue decreased by 10% to HK$44587 million[71] Telecommunications - 3 Group Europe - 3 Group Europe's total revenue increased by 5% to HK$41958 million[38] - Underlying EBITDA increased by 7% to HK$11816 million[38] - Active customer base increased by 40% to 566 million[108] Financial Position - Liquid assets totaled $1373 billion, sufficient to cover all debt maturing before December 2028[21] - Net Debt Ratio was 147%[7] - Group GHG performance reduced scope 1 + 2 emissions by approximately 20% against 2020 baseline[54]